Generated from latest updates

AI Daily Brief

3 signals

Two payers published first-ever Dawnzera policy this week — both landed with step therapy against Takhzyro. Tryngolza (sHTG) gained a favorable TG-threshold simplification at Aetna; FCS genetic-testing criteria still needs source confirmation at three plans.

Dawnzera new policysHTG upsideFCS watch

Latest Coverage Updates

8 of 8 sourced policy records from published payer documents

Dawnzera (HAE)

UnitedHealthcare · National

Published — RestrictedSourced

Listed on UnitedHealthcare's Prior Authorization / Medical Necessity required drug list for commercial plans. Specific clinical criteria not captured in this summary — pull the full policy document for detail.

Authorization duration: Not specified in summary

Effective Not specified in summary 340 treated livesCommercialMedicare Part DManaged Medicaid

Dawnzera (HAE)

Alaska Medicaid · Alaska

Published — RestrictedSourced

State-specific PA criteria document published; detail not fully captured in this summary — pull the full policy document.

Authorization duration: Not specified in summary

Effective Not specified in summary 10 treated livesMedicaid FFS

Tryngolza (FCS)

Aetna Better Health (Medicaid, multi-state) · Multi-state

Published — RestrictedSourced

Confirmed FCS diagnosis by genetic testing (biallelic pathogenic variants in LPL, GPIHBP1, APOA5, APOC2, LMF1, GPD1, or CREB3L3), or if genetic testing is inconclusive, a clinical diagnosis using Moulin or NAFCS scoring criteria.

Authorization duration: 6-12 months depending on state

Effective 2026-06-01 150 treated livesManaged Medicaid

Dawnzera (HAE)

Louisiana Medicaid · Louisiana

Published — FavorableSourced

Confirmed HAE diagnosis, minimum age 12. Continuation requires documented positive response and confirmation the patient is not concurrently on another HAE prophylaxis medication.

Authorization duration: 12 months (initiation and continuation)

Effective 2026-04-01 24 treated livesMedicaid FFS

Tryngolza (sHTG)

Centene · National

Published — RestrictedSourced

Fasting triglycerides >= 500 mg/dL required for the hypertriglyceridemia authorization bucket, separate from the FCS-specific genetic criteria (Coordinated Care, Medicaid MI - PEPP).

Authorization duration: Not specified in summary

Effective 2026-01-01 1,260 treated livesManaged MedicaidMedicare Part D

Tryngolza (FCS)

CareSource (Marketplace, MI) · Michigan

Published — RestrictedSourced

Must be prescribed by or in consultation with an endocrinologist, cardiologist, or lipid specialist. Diagnosis of FCS confirmed by genetic test.

Authorization duration: 6 months initial

Effective 2025-07-01 48 treated livesMarketplace

Tryngolza (FCS)

Cigna Healthcare · National

Published — RestrictedSourced

Prior authorization required. Initial approval requires prescribing by or in consultation with a specialist in the condition. Extensive documentation required (chart notes, labs, genetic test results).

Authorization duration: Not specified in summary

Effective 2025-06-15 600 treated livesCommercialMedicare Part D

Tryngolza (FCS)

Wellmark BCBS · Iowa / South Dakota

Published — RestrictedSourced

Initial authorization of 6 months for FCS. Considered not medically necessary if criteria unmet. Manufacturer financial assistance program participation referenced as part of initial approval process.

Authorization duration: 6 months

Effective 2025-01-01 60 treated livesCommercial